AK138D1
Sponsors
Akeso
Conditions
Breast CancerNon-Small Cell Lung CancerSolid Cancer
Phase 1
A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors
RecruitingNCT06730386
Start: 2025-02-24End: 2028-08-30Target: 100Updated: 2025-03-06
A Study of AK138D1 in Advanced Malignant Tumors
RecruitingNCT07281326
Start: 2025-10-22End: 2028-05-30Target: 200Updated: 2025-12-15
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer
Not yet recruitingNCT07560124
Start: 2026-06-06End: 2030-09-14Target: 286Updated: 2026-04-30
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer
Not yet recruitingNCT07623356
Start: 2026-06-18End: 2030-07-03Target: 265Updated: 2026-06-03